Corneal complications associated with topical ophthalmic use of nonsteroidal antiinflammatory drugs

Journal of Cataract and Refractive Surgery

Volumn 27, Issue 4, 2001, Pages 622-631

  Congdon, Nathan G ^a,c   Schein, Oliver D ^a,b,c,d   Von Kulajta, Petra ^b,c   Lubomski, Lisa H ^a,c   Gilbert, Donna ^a,c   Katz, Joanne ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Cornea and Anterior Segment Service ^*  (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d 116 Wilmer Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; GENERIC DRUG; KETOROLAC TROMETAMOL; NONSTEROID ANTIINFLAMMATORY AGENT; EYE DROPS;

ADULT; AGED; ARTICLE; CATARACT; CORNEA DISEASE; CORNEA ULCER; DISEASE SEVERITY; DRUG USE; EYE DISEASE; EYE SURGERY; FEMALE; GLAUCOMA; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PAIN; PRIORITY JOURNAL; REFRACTION ERROR; RISK FACTOR; CHEMICALLY INDUCED DISORDER; CORNEA; DRUG EFFECT; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CORNEA; CORNEAL DISEASES; FEMALE; HUMANS; MALE; OPHTHALMIC SOLUTIONS;

EID: 0035320753     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0886-3350(01)00801-X     Document Type: Article

References (34)

1. Nichols J, Snyder RW. Topical nonsteroidal anti-inflammatory agents in ophthalmology. Curr Opin Ophthalmol 1998; 9(4):40-44
2. Flach AJ, Jampol LM, Weinberg D, et al. Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine. Am J Ophthalmol 1991; 112:514-519
3. Italian Diclofenac Study Group. Efficacy of diclofenac eyedrops in preventing postoperative inflammation and long-term cystoid macular edema. J Cataract Refract Surg 1997; 23:1183-1189
4. Weisz JM, Bressler NM, Bressler SB, Schachat AP. Ketorolac treatment of pseudophakic cystoid macular edema identified more than 24 months after cataract extraction. Ophthalmology 1999; 106:1656-1659
5. Miyake K, Masuda K, Shirato S, et al. Comparison of diclofenac and fluorometholone in preventing cystoid macular edema after small incision cataract surgery: a multicentered prospective trial. Jpn J Ophthalmol 2000; 44:58-67
6. Tinkelman DG, Rupp G, Kaufman H, et al. Double-masked, paired-comparison clinical study of ketorolac tromethamine 0.5% ophthalmic solution compared with placebo eyedrops in the treatment of seasonal allergic conjunctivitis. Surv Ophthalmol 1993; 38:133-140
7. Tauber J, Raizman MB, Ostrov CS, et al. A multicenter comparison of the ocular efficacy and safety of diclofenac 0.1% solution with that of ketorolac 0.5% solution in patients with acute seasonal allergic conjunctivitis. J Ocular Pharmacol Ther 1998; 14:137-145
8. Stewart R, Grosserode R, Cheetham JK, Rosenthal A. Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced miosis during cataract surgery. Clin Ther 1999; 21:723-732
9. Frucht-Pery J, Siganos CS, Solomon A, et al. Topical indomethacin solution versus dexamethasone solution for treatment of inflamed pterygium and pinguecula: a prospective randomized clinical study. Am J Ophthalmol 1999; 127:148-152
10. Kaiser PK, Pineda R II. A study of topical nonsteroidal anti-inflammatory drops and no pressure patching in the treatment of corneal abrasions. Ophthalmology 1997; 104:1353-1359
11. Szucs PA, Nashed AH, Allegra JR, Eskin B. Safety and efficacy of diclofenac ophthalmic solution in the treatment of corneal abrasions. Ann Emerg Med 2000; 35:131-137
12. Goethals M, Missotten L. Efficacy and safety of indomethacin 0.1% versus flurbiprofen 0.03% eyedrops in inflammation after argon laser trabeculoplasty. Doc Ophthalmol 1994; 85:287-293
13. Flach AJ, Dolan BJ, Donahue ME, et al. Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery. Ophthalmology 1998; 105:1775-1779
14. Heier J, Cheetham JK, Degryse R, et al. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial. Am J Ophthalmol 1999; 127:253-259
15. Simone JN, Pendelton RA, Jenkins JE. Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery. J Cataract Refract Surg 1999; 25:699-704
16. Kent AR, Dubiner HB, Whitaker R, et al. The efficacy and safety of diclofenac 0.1% versus prednisolone acetate 1% following trabeculectomy with adjunctive mitomycin-C. Ophthalmic Surg Lasers 1998; 29:562-569
17. Weinstock VM, Weinstock DJ, Weinstock SJ. Diclofenac and ketorolac in the treatment of pain after photorefractive keratectomy. J Refract Surg 1996; 12:792-794
18. Rajpal RK, Cooperman BB. Analgesic efficacy and safety of ketorolac after photorefractive keratectomy. J Refract Surg 1999; 15:661-667
19. Apt L, Voo I, Isenberg SJ. A randomized clinical trial of the nonsteroidal eyedrop diclofenac after strabismus surgery. Ophthalmology 1998; 105:1449-1452; discussion by SP Kraft, 1453-1454
20. Sun R, Gimbel HV. Effects of topical ketorolac and diclofenac on normal corneal sensation. J Refract Surg 1997; 13:158-161
21. Shimazaki J, Saito H, Yang H-Y, et al. Persistent epithelial defects following penetrating keratoplasty: an adverse effect of diclofenac eyedrops. Cornea 1995; 14:623-627
22. Gills JP. Voltaren associated with medication keratitis (letter). J Cataract Refract Surg 1994; 20:110
23. Sher NA, Krueger RR, Teal P, et al. Role of topical corticosteroids and nonsteroidal antiinflammatory drugs in the etiology of stromal infiltrates after excimer photorefractive keratectomy (letter). J Refract Corneal Surg 1994; 10:587-588
24. Probst LE, Machat JJ. Corneal subepithelial infiltrates following photorefractive keratectomy (letter). J Cataract Refract Surg 1996; 22:281
25. Lin JC, Rapuano CJ, Laibson PR, et al. Corneal melting associated with use of topical nonsteroidal anti-inflammatory drugs after ocular surgery. Arch Ophthalmol 2000; 118:1129-1132
26. Flach A. Topically applied nonsteroidal anti-inflammatory drugs and corneal problems: an interim review and comment (editorial). Ophthalmology 2000; 107:1224-1226
27. Hatchell DL, Magolan JJ Jr, Besson MJ, et al. Damage to the epithelial basement membrane in the corneas of diabetic rabbits. Arch Ophthalmol 1983; 101:469-471
28. Herse PR. A review of manifestations of diabetes mellitus in the anterior eye and cornea. Am J Optom Physiol Opt 1988; 65:224-230
29. Azar DT, Spurr-Michaud SJ, Tisdale AS, Gipson IK. Decreased penetration of anchoring fibrils into the diabetic stroma; a morphometric analysis. Arch Ophthalmol 1989; 107:1520-1523
30. Azar DT, Spurr-Michaud SJ, Tisdale AS, Gipson IK. Altered epithelial-basement membrane interactions in diabetic corneas. Arch Ophthalmol 1992; 110:537-540
31. Ljubimov AV, Huang ZS, Huang GH, et al. Human corneal epithelial basement membrane and integrin alterations in diabetes and diabetic retinopathy. J Histochem Cytochem 1998; 46:1033-1041
32. Tomas-Barberan S, Fagerholm P. Influence of topical treatment on epithelial wound healing and pain in the early postoperative period following photorefractive keratectomy. Acta Ophthalmol Scand 1999; 77:135-138
33. Hersh PS, Rice BA, Baer JC, et al. Topical nonsteroidal agents and corneal wound healing. Arch Ophthalmol 1990; 108:577-583
34. Lu KL, Wee WR, Sakamoto T, McDonnell PJ. Comparison of in vitro antiproliferative effects of steroids and nonsteroidal antiinflammatory drugs on human keratocytes. Cornea 1996; 15:185-190